UPDATE 1-Regeneron eye drug sales grow, but fall short of expectations
May 08, 2014 at 10:11 AM EDT
May 8 (Reuters) - U.S. sales of Regeneron Pharmaceuticals Inc's eye drug Eylea missed market estimates due to a drop in distributor inventory and a severe U.S. winter that prevented patients from visiting clinics to receive the treatment.